Innovative Targeting Solutions to Present at the 2016 Antibody Engineering and Therapeutics Annual Meeting on Novel BioSensor Display Platform
December 7, 2016
Vancouver, BC – December 7th, 2016 – Innovative Targeting Solutions Inc (ITS) will be presenting an extension of their HuTARG platform termed BioSensor Display. This new platform leverages the diversity generating power of the HuTARG system and cell based biosensors and provides unprecedented sensitivity and ease for doing drug discovery. BioSensor Display transforms the ability of scientists to target GPCRs, ion channels and other complex membrane receptors utilizing intact cells natively expressing the target.
The presentation will take place Monday December 12th @ 1:15pm during a scientific briefing in a talk titled: The Use of BioSensor Display Libraries in Antibody Discovery
About Innovative Targeting Solutions Inc.
Founded in 2008, Innovative Targeting Solutions Inc. is a privately-held company that has developed a next generation protein engineering platform for the generation of fully human antibody and T cell receptor based therapeutics using its proprietary HuTARG technology. The HuTARG technology is a fully mammalian technology that generates antibody diversity in vitro via RAG1/RAG2 mediated V(D)J recombination.